Depression and Anxiety Trial, Not Yet Recruiting NCT06571071 Sponsor: Herbolab India Pvt. Ltd. Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Not Yet Recruiting

NCT06571071
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults aged 21 to 50 years (male or female) are eligible to be considered.
  • People who report experiencing mild to moderate stress, based on a standard stress questionnaire (PSS score of 26 or below).
  • People who are willing to take part in a clinical trial and have read, understood, and signed a consent form.
  • People who do not have severe anxiety or depression, based on standard questionnaire scores (GAD score of 10 or below, and PHQ-9 score of 14 or below).
  • Women who could become pregnant must have a negative pregnancy test and agree to use contraception for the full duration of the study.
  • People with no history of substance use disorder, apart from nicotine or occasional alcohol use — and who have not used those substances in the last 14 days and agree not to use them during the trial.
  • People who are willing to reduce their caffeine intake while taking part in the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are unable to complete the assessments required by the trial.
  • People who show signs of dementia, such as that caused by Alzheimer's Disease, AIDS, Creutzfeldt-Jakob disease, Lewy Body dementia, cerebrovascular dementia, Progressive Supranuclear Palsy, multiple strokes, or normal pressure hydrocephalus.
  • People who are currently taking any supplements — whether nutritional, conventional medicine-based, or herbal/Ayurvedic — for managing stress.
  • People who have any other neurodegenerative (brain-degenerating) disease or a seizure disorder.
  • People who are known to have a sensitivity or allergic reaction to the products being investigated in this trial.
  • People who have been diagnosed with cancer within the past 5 years, or who currently have a cancer diagnosis.
  • Women who are pregnant, breastfeeding, or who could become pregnant and are not using contraception or plan to conceive during the study.
  • People whose resting blood pressure is very high — specifically, a top number (systolic) above 180 mmHg or a bottom number (diastolic) above 110 mmHg at the screening visit.
  • People with a history of substance misuse, including drugs, heavy alcohol use, or smoking within the last 5 years.
  • People with a serious illness or any other condition that, in the opinion of the trial doctor, could affect their safety or ability to complete the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Herbolab India Pvt. Ltd.
Registry
ClinicalTrials.gov
Start date
5 September 2024
Est. completion
25 November 2024

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

Perceived Stress Scale; Changes in Creatine kinase; Changes in Lactate dehydrogenase(LDH); Body Mass Index (BMI); Mental chatter 5-point scale; Assessment of anxiety using Hamilton Anxiety Rating Scale (HAM-A); COPE Questionnaire; STAI (State-Trait Anxiety Inventory); visual analogue scale; Changes in serum cortisol levels; Change in serum serotonin levels; Changes in Modified sleep regularity and medication withdrawal questionnaire (MSRMWQ); Change in mood assessed using the Profile of Mood States (POMS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov